CVS Group plc
10 January 2008
For Immediate Release 10 January 2008
CVS Group plc
('CVS' or 'the Group')
Acquisition of Axiom Veterinary Laboratories ('Axiom Lab')
- Doubles Group Revenues in Diagnostic Laboratory Services
CVS, one of the UK's leading providers of veterinary services, is pleased to
announce the acquisition of Axiom Lab. Founded in 1980, Axiom Lab provides
diagnostic laboratory services to third party veterinary practices. CVS'
existing three diagnostic laboratories specialise in histology and represented
7% of Group turnover in the year ended 30 June 2007. Axiom Lab complements the
Group's diagnostic operations by bringing a strength and specialisation in
biochemistry, as well as allergy testing, to its range of services. It will also
double Group revenues derived from laboratory services.
Management accounts for the year ended 31 December 2007 show that Axiom Lab
achieved EBITDA of approximately £700,000 on turnover of approximately £4.5
million. The £4.039m consideration is being satisfied wholly in cash.
Axiom Lab employs 10 vets across three sites and the team will remain with CVS
after acquisition. We are pleased that owner, Peter Webb, will remain full time
with the business as Managing Director of Axiom Lab.
Commenting on the acquisition, CVS Chief Executive Simon Innes said 'Axiom Lab's
biochemistry specialisation provides the perfect complement to our existing
diagnostic services. We welcome the Axiom Lab team to CVS and look forward to
the benefits of their considerable reputation in their specialist field.'
Contacts:
CVS Group plc 01379 644 288
Simon Innes, Chief Executive
Paul Coxon, Finance Director
Buchanan Communications 0207 466 5000
Richard Oldworth
Suzanne Brocks
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.